Moreover, bavachin promoted lipid accumulation in 3T3-L1 cells at differentiation day 8 by activating gene expression of peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer binding protein alpha (C/EBPα) [45], suggesting that bavachin might have therapeutic potential for type 2 diabetes. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.